-transparent.png){kind=logo}
Two human volunteer studies were performed with meropenem: a dose proportionality study of 0.25, 0.5 and 1.0 g and a probenecid interaction study. Six volunteers took part in each study. Meropenem was generally well tolerated: One volunteer was withdrawn from the dose proportionality study because of looseness of stool and abdominal pain after a dose of 1.0 g. The plasma concentrations of meropenem were linearly related to dose. The half-life of meropenem was approximately 1 h and the urinary recovery of unchanged drug was 79%. In the presence of probenecid the plasma half-life of meropenem was increased by 33% but the urinary recovery was unaffected.
Related Publications
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
February 1997,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
January 1995,
Scandinavian journal of infectious diseases. Supplementum,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
September 2009,
Antimicrobial agents and chemotherapy,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
April 1995,
Clinical pharmacokinetics,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
June 2001,
Therapeutic drug monitoring,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
April 1993,
The Journal of dermatology,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
November 2010,
The Journal of antimicrobial chemotherapy,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
December 2005,
International journal of antimicrobial agents,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
January 1992,
European journal of clinical pharmacology,
R P Bax, and
W Bastain, and
A Featherstone, and
D M Wilkinson, and
M Hutchison, and
S J Haworth
December 1998,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
